Debatable Issues in Palliative Sedation; Authors' Reply to the Response by Robert Twycross
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Won, Young-Woong | - |
dc.contributor.author | Kang, Jung Hun | - |
dc.date.accessioned | 2021-08-02T09:27:51Z | - |
dc.date.available | 2021-08-02T09:27:51Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 0885-3924 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/9834 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Debatable Issues in Palliative Sedation; Authors' Reply to the Response by Robert Twycross | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Won, Young-Woong | - |
dc.identifier.doi | 10.1016/j.jpainsymman.2020.01.010 | - |
dc.identifier.scopusid | 2-s2.0-85083673984 | - |
dc.identifier.wosid | 000530704700002 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, v.59, no.5, pp.E2 - E3 | - |
dc.relation.isPartOf | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | - |
dc.citation.title | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | - |
dc.citation.volume | 59 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | E2 | - |
dc.citation.endPage | E3 | - |
dc.type.rims | ART | - |
dc.type.docType | Letter | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | benzodiazepine | - |
dc.subject.keywordPlus | haloperidol | - |
dc.subject.keywordPlus | lorazepam | - |
dc.subject.keywordPlus | midazolam | - |
dc.subject.keywordPlus | agitation | - |
dc.subject.keywordPlus | consciousness level | - |
dc.subject.keywordPlus | continuous deep sedation | - |
dc.subject.keywordPlus | deep sedation | - |
dc.subject.keywordPlus | delirium | - |
dc.subject.keywordPlus | hospital patient | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | Letter | - |
dc.subject.keywordPlus | palliative therapy | - |
dc.subject.keywordPlus | propensity score | - |
dc.subject.keywordPlus | prospective study | - |
dc.subject.keywordPlus | sedation | - |
dc.subject.keywordPlus | survival time | - |
dc.subject.keywordPlus | terminal disease | - |
dc.subject.keywordPlus | conscious sedation | - |
dc.subject.keywordPlus | longitudinal study | - |
dc.subject.keywordPlus | neoplasm | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0885392420300622?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.